Delphos Brings Crucial Access to Funding for SMEs in LATAM, says Bart Turtelboom, Chairman

January 23th, 2025, SANTIAGO, CHILE – Delphos brings crucial access to funding for SMEs in the Latam region. Maxxa, a leading Chilean fintech focused on serving SMEs, has closed a $10.6M transaction with Symbiotics, a premier Swiss-based impact-focused fund manager.

This deal advances milestones in the mission to tackle one of Latin America’s most pressing challenges—the high failure rate of SMEs due to lack of financing—while expanding Maxxa’s reach across the region through international capital markets.

 CEO and Chairman of Delphos, Bart Turtelboom, said:

“We recognize Maxxa’s innovative approach to SME funding, which has positioned the company as a leader in financial inclusion. We foresee ripple effects throughout Chile’s NBFI business landscape. It sends a positive signal to both domestic and international investors about the vitality and potential of Chile’s SME sector.”

Maxxa’s technological platform enables SMEs to obtain a credit assessment in minutes, revolutionizing the traditional loan application process. This agility and efficiency in credit evaluation demonstrates the effectiveness of Maxxa’s enhanced capacity to secure loans for its clients, which will address this critical gap using innovation and improving access to financing.

Symbiotics, as a leader in impact finance, played a crucial role in facilitating the transaction by bridging global investors with local opportunities. This partnership aligns with Symbiotics’ mission of advancing financial inclusion and economic resilience in underserved markets.

Jérôme Birolini, Regional Manager for the Latin America region at Symbiotics added:

“At Symbiotics, we are dedicated to unlocking capital for impactful initiatives in emerging and frontier markets. Partnering with Maxxa and Delphos allows us to create meaningful solutions that empower SMEs and strengthen economic growth in Chile.”

Cristian Sauterel Durán, CEO of Maxxa, added:

“This deal represents a pivotal moment not just for Maxxa but for the entire SME sector in the region. By strengthening our capacity to provide long-term loans at favorable terms, we’re setting the stage for unprecedented growth and stability for our clients.”

One key feature of Maxxa’s offering is the provision of long-term loans with maturities of up to three years. This extended timeframe is crucial for small companies seeking to establish a stable financial foundation and pursue sustainable growth strategies. By facilitating access to credit that might otherwise be out of reach, Maxxa plays a vital role in improving conditions for SME growth.

The impact of this deal addresses the United Nations SDG 17 goals. SMEs, which form the backbone of Chile’s economy, often struggle to secure the funding necessary for sustainable development, innovation, and job creation.

Global financial consulting firm Delphos was instrumental in securing the financing Maxxa needed to empower Chile’s SMEs, driving investor confidence in the opportunity and fostering familiarity with the jurisdiction. This transaction exemplifies Delphos’ interest and emphasis in Latin America as a region ripe with opportunities for the international capital markets.

– THE END –

About Maxxa:

Gomaxxa.com
Founded in 2016, Maxxa is a Chilean fintech offering comprehensive financial products and services that empower small- and medium-sized enterprises (SMEs) to grow and improve their financial health. The Company leverages cutting-edge technology and personalized services to provide underbanked SMEs access to credit and other financial services, driving greater financing inclusion and economic growth. Maxxa has established itself as a cornerstone in Chile’s non-bank financial ecosystem by offering innovative digital loans to SMEs that enable them access to attractive sources of capital in the capital markets, encouraging competition in the market for SME funding, which traditional banks have poorly served.

About Symbiotics

Symbioticsgroup
Symbiotics is the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies. The group offers investment, asset management and capacity building services. Since 2005, we have originated over 8,200 investments representing more than USD 10.5 billion for 608 companies in 99 countries. We manage an aggregate portfolio of USD 2.8 billion spread across 20 funds and mandates. Our portfolio companies have also benefited from over 170 technical assistance projects worth more than USD 19 million.

About Delphos

Delphos.co
Founded in Washington, DC, Delphos has 37 years of advisory experience in emerging markets. It specializes in capital raising and transaction advisory and operates in 25 cities worldwide. Delphos has a strong track record in securing competitively priced capital and providing expertise to the public and private sectors.

Media Contact:
Delphos : Caroline Ah King
[email protected] 

Symbiotics : Samy Derradji
Head of Communications
[email protected]

Send us your press releases to [email protected]